These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25881865)
1. Expression Profile of Autophagy-related Markers in Localized Prostate Cancer: Correlation With Biochemical Recurrence After Radical Prostatectomy. Liu B; Miyake H; Nishikawa M; Tei H; Fujisawa M Urology; 2015 Jun; 85(6):1424-30. PubMed ID: 25881865 [TBL] [Abstract][Full Text] [Related]
2. Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy. Behnsawy HM; Miyake H; Harada K; Fujisawa M BJU Int; 2013 Jan; 111(1):30-7. PubMed ID: 23107154 [TBL] [Abstract][Full Text] [Related]
3. Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomy. Tei H; Miyake H; Harada K; Fujisawa M Urol Oncol; 2014 Jul; 32(5):694-700. PubMed ID: 24468288 [TBL] [Abstract][Full Text] [Related]
4. Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Miyake H; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M Urol Oncol; 2010; 28(2):145-51. PubMed ID: 18848789 [TBL] [Abstract][Full Text] [Related]
5. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
6. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [TBL] [Abstract][Full Text] [Related]
8. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649 [TBL] [Abstract][Full Text] [Related]
10. Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Kumano M; Miyake H; Muramaki M; Furukawa J; Takenaka A; Fujisawa M Urol Oncol; 2009; 27(2):180-6. PubMed ID: 18439850 [TBL] [Abstract][Full Text] [Related]
11. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Miyake H; Sakai I; Harada K; Eto H; Hara I Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782 [TBL] [Abstract][Full Text] [Related]
12. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536 [TBL] [Abstract][Full Text] [Related]
13. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors for biochemical recurrence after radical prostatectomy in patients with clinically localized prostate cancer. Implications of adjuvant treatment]. Fagundo EV; Amo FH; López EL; Sánchez JP; Jiménez Gdel P; Chamizo JA; Cordero JM; Fernández ME; Fernández CH Arch Esp Urol; 2012; 65(1):158-65. PubMed ID: 22318186 [TBL] [Abstract][Full Text] [Related]
15. [Preoperative predictive model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy]. Molina Escudero R; Herranz Amo F; Paez Borda A; Hernández Fernández C Arch Esp Urol; 2013; 66(6):567-75. PubMed ID: 23985457 [TBL] [Abstract][Full Text] [Related]
16. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864 [TBL] [Abstract][Full Text] [Related]
17. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Kurahashi T; Miyake H; Hara I; Fujisawa M J Urol; 2007 Feb; 177(2):757-61. PubMed ID: 17222676 [TBL] [Abstract][Full Text] [Related]
18. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence. Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829 [TBL] [Abstract][Full Text] [Related]
19. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report. Li K; Li H; Yang Y; Ian LH; Pun WH; Ho SF Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957 [TBL] [Abstract][Full Text] [Related]
20. Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer? Servoll E; Saeter T; Vlatkovic L; Nesland J; Waaler G; Beisland HO Scand J Urol Nephrol; 2010 Sep; 44(4):217-22. PubMed ID: 20367396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]